UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031306
Receipt number R000035456
Scientific Title Study of the ease of taking placebo formulations assuming an oral dosage form containing large amount of drug.
Date of disclosure of the study information 2018/02/16
Last modified on 2019/02/02 16:55:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the ease of taking placebo formulations assuming an oral dosage form containing large amount of drug.

Acronym

The ease of taking placebo formulation of large amount of drug.

Scientific Title

Study of the ease of taking placebo formulations assuming an oral dosage form containing large amount of drug.

Scientific Title:Acronym

The ease of taking placebo formulation of large amount of drug.

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify differences of the ease of taking placebo formulations(powder,granule and micro-tablets) assuming an oral dosage form containing large amount of drugs.

Basic objectives2

Others

Basic objectives -Others

The ease of taking

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The amount of water required for intake of tablets

Key secondary outcomes

Visual analogue scale
5-point scale


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

6

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

micro tablet

Interventions/Control_2

granule formulation

Interventions/Control_3

powder formulation

Interventions/Control_4

micro-tablets containing a bitterness material

Interventions/Control_5

granule containing a bitterness material

Interventions/Control_6

powder containing a bitterness material

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy 20-40 year-old volunteers(male and female)

Key exclusion criteria

1)People who have hardness for swallowing
2)People who have an extraordinary state in throat.
3)People who have allergy about citron or citrus fruits.
4)Other who was decided as inadequate by research contact person.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Namiki Noriyuki

Organization

School of Pharmaceutical Sciences University of Shizuoka

Division name

Department of Pharmacy Practice and Science

Zip code


Address

52-1, Yada, Suruga, Shizuoka

TEL

054-264-5237

Email

namiki@u-shizuoka-ken.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Uchida Shinya

Organization

School of Pharmaceutical Sciences University of Shizuoka

Division name

Department of Pharmacy Practice and Science

Zip code


Address

52-1, Yada, Suruga, Shizuoka

TEL

054-264-5234

Homepage URL


Email

uchidas@u-shizuoka-ken.ac.jp


Sponsor or person

Institute

School of Pharmaceutical Sciences University of Shizuoka,Department of Pharmacy Practice and Science

Institute

Department

Personal name



Funding Source

Organization

Kissei Pharmaceutical Co., Ltd

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

静岡県立大学(静岡県)


Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 16 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 12 Month 26 Day

Date of IRB


Anticipated trial start date

2018 Year 02 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 14 Day

Last modified on

2019 Year 02 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035456


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name